New Mucinex® GeoVitalPredictor (GVP) Puts Americans A Step Ahead...

New Mucinex® GeoVitalPredictor (GVP) Puts Americans A Step Ahead of the Cold and Flu Outbreaks

By Healthcare Tech Outlook | Friday, September 11, 2020

The new model predicts where and when the seasonal sickness will hit the hardest and helps to get communication, care, and relief there sooner.

FREMONT, CA: Knowing where sickness will break is more than half the battle. Mucinex® is a leading cold and flu brand with a fighting spirit is joining forces with Kinsa in a first-of-its-kind partnership to get ahead of sickness by using state-of-the-art predictive data to intimate and power its nationwide supply chain and the inventory management system and help to direct its health advice to the consumers where and when they need it the most.

Their new GeoVitalPredictor taps Kinsa's aggregate, county-level population health insights and  12-week advance forecasting model to formulate the most sophisticated and informed end-to-end supply delivery process while improving the brand's ability to share localized healthcare messages to the consumers who are in the urgent need of relief from cold and flu symptoms.

In the early stages of the COVID-19 pandemic, consumers throughout the country were inundated with conflicting healthcare messages and also saw empty store shelves. As a result, worries increased from conflicting healthcare messages and having access to necessary supplies, including go-to over-the-counter remedies.

The Kinsa system comprises of an internet-connected smart thermometer that syncs to a mobile app. It guides the users to the care they need to get better faster, while simultaneously aggregating early indicators of illness, "including fever"to understand where and when the illness is spreading. With above two million thermometers expected in circulation by the Fall of 2020, aggregating health insights from more than four million people, Kinsa can accurately predict as far out as 12-weeks in advance where in the U.S. sickness will start and how quickly it will spread. Equipped with this information, Mucinex will be able to see where cold and flu relief is needed most and nimbly direct the supply of its cold and flu remedy to retail locations in counties where outbreaks are happening, and consumer need and demand are high.

"The last thing you want to worry about when you're sick and hoping to recover fast is your go-to medicine being out of stock," says Claudine Patel, Vice President, Marketing for Mucinex. "Our job is to make people feel better, and this predictive technology allows Mucinex to work nimbly with retailers across the country to bring our proven relief to store shelves at the exact time and location our consumers need it most. With our new "GeoVitalPredictor" model, we have even more knowledge and agility to help fight sickness before it happens and also to better direct our communication efforts and advice to the people who want to feel better fast."

Weekly Brief